Adiponectin association with T‐cadherin protects against neointima proliferation and atherosclerosis
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Adiponectin, an adipocyte‐derived protein abundant in the circulation, is thought to be protective against atherosclerosis. However, it is not fully understood how the association of adiponectin with vascular cells and its antiatherogenic effect are connected. In this study, T‐cadherin was essential for accumulation of adiponectin in the neointima and atherosclerotic plaque lesions, and the adiponectin–T‐cadherin association protected against vascular injury. In the apolipoprotein E‐knockout (ApoE‐KO) mice, adiponectin and T‐cadherin colocalized on en‐dothelial cells and synthetic smooth muscle cells in the aortic intima. Notably, aortic adiponectin protein disappeared in T‐cadherin/ApoE double‐knockout (Tcad/ApoE‐DKO) mice with significant elevation of blood adiponectin concentration. Furthermore, in Tcad/ApoE‐DKO mice, carotid artery ligation resulted in a significant increase of neointimal thickness compared with ApoE‐KO mice. Finally, on a high‐cholesterol diet, Tcad/ApoE‐DKO mice increased atherosclerotic plaque formation, despite a 5‐fold increase in plasma adiponectin level compared with that in ApoE‐KO mice. In vitro , knockdown of T‐cadherin from human aortic smooth muscle cells (HASMCs) with synthetic phenotype significantly reduced adiponectin accumulation on HASMCs and negated the inhibitory effect of adiponectin on proinflammatory change. Collective evidence showed that adiponectin accumulates in the vasculature via T‐cadherin, and the adiponectin–T‐cadherin association plays a protective role against neointimal and atheroscle‐rotic plaque formations. —Fujishima, Y., Maeda, N., Matsuda, K., Masuda, S., Mori, T., Fukuda, S., Sekimoto, R., Yamaoka, M., Obata, Y., Kita, S., Nishizawa, H., Funahashi, T., Ranscht, B., Shimomura, I. Adiponectin association with T‐cadherin protects against neointima proliferation and atherosclerosis. FASEB J . 31, 1571–1583 (2017) www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Self-citationCloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176 · cited 6×
“T-cadherin protein is extremely low in liver tissue and hepatocytes (23), but AdipoR1/R2 are present in liver, although plasma adiponectin level was not changed in mice lacking AdipoR1/R2 (54).”
BackgroundInfluentialReceptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892 · cited 6×
“T-cadherin protein is extremely low in liver tissue and hepatocytes (23), but AdipoR1/R2 are present in liver, although plasma adiponectin level was not changed in mice lacking AdipoR1/R2 (54).”
BackgroundInfluentialTherapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease
Matsuzawa, Y. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0380 · Cited by 434 · cited 1×
“Obesity, especially obesity associated with visceral fat accumulation, is linked to metabolic syndrome and cardiovascular disease (1, 2).”
BackgroundWang, Y., Wang, X., Lau, W. B., Yuan, Y., Booth, D., Li, J.-J., Scalia, R., Preston, K., Gao, E., Koch, W., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.302439 · Cited by 104
Cited by
Adiponectin regulation and function
Fang, H., & Judd, R. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170046 · Cited by 631
Cardoso, A. L., Fernandes, A., Aguilar-Pimentel, J. A., de Angelis, M. H., Guedes, J. R., Brito, M. A., Ortolano, S., Pani, G., Athanasopoulou, S., Gonos, E. S., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.004 · Cited by 475
Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome
Kita, S., Maeda, N., & Shimomura, I. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129193 · Cited by 273
Self-citationAdiponectin promotes muscle regeneration through binding to T-cadherin
Tanaka, Y., Kita, S., Nishizawa, H., Fukuda, S., Fujishima, Y., Obata, Y., Nagao, H., Masuda, S., Nakamura, Y., Shimizu, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37115-3 · Cited by 103
Self-citationAdipoRon’s Impact on Alzheimer’s Disease—A Systematic Review and Meta-Analysis
Barbalho, S. M., Laurindo, L. F., de Oliveira Zanuso, B., da Silva, R. M. S., Gallerani Caglioni, L., Nunes Junqueira de Moraes, V. B. F., Fornari Laurindo, L., Dogani Rodrigues, V., da Silva Camarinha Oliveira, J., Beluce, M. E., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020484 · Cited by 18
“…studies elucidated that adiponectin binding to T-cadherin protects against neointima proliferation and atherosclerosis, which protects individuals against dementia since atherosclerosis is intimately associated with the occurrence of AD [71,72]. isoforms, but not trimeric or spherical forms [70].”
Metadata
- Authors
- Fujishima, Y., Maeda, N., Matsuda, K., Masuda, S., Mori, T., Fukuda, S., Sekimoto, R., Yamaoka, M., Obata, Y., Kita, S., Nishizawa, H., Funahashi, T., Ranscht, B., & Shimomura, I.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2017-01-06
- Volume
- 31
- Issue
- 4
- Pages
- 1571-1583
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2570064302
- Cited by
- 119
- References
- 5
- FWCI
- 9.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.